# Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

> **NCT03731715** · PHASE1 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Lennox Gastaut Syndrome

## Interventions

- **DRUG:** Carisbamate

## Key facts

- **NCT ID:** NCT03731715
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-07
- **Primary completion:** 2022-05-23
- **Final completion:** 2022-06-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03731715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03731715, "Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03731715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*